@article{b5f631595502452b89368ba5779d9f55,
title = "Surgical treatment for recurrent shoulder instability: factors influencing surgeon decision making",
abstract = "Background: The optimal surgical approach for recurrent anterior shoulder instability remains controversial, particularly in the face of glenoid and/or humeral bone loss. The purpose of this study was to use a contingent-behavior questionnaire (CBQ) to determine which factors drive surgeons to perform bony procedures over soft tissue procedures to address recurrent anterior shoulder instability. Methods: A CBQ survey presented each respondent with 32 clinical vignettes of recurrent shoulder instability that contained 8 patient factors. The factors included (1) age, (2) sex, (3) hand dominance, (4) number of previous dislocations, (5) activity level, (6) generalized laxity, (7) glenoid bone loss, and (8) glenoid track. The survey was distributed to fellowship-trained surgeons in shoulder/elbow or sports medicine. Respondents were asked to recommend either a soft tissue or bone-based procedure, then specifically recommend a type of procedure. Responses were analyzed using a multinomial-logit regression model that quantified the relative importance of the patient characteristics in choosing bony procedures. Results: Seventy orthopedic surgeons completed the survey, 33 were shoulder/elbow fellowship trained and 37 were sports medicine fellowship trained; 52% were in clinical practice ≥10 years and 48% <10 years; and 95% reported that the shoulder surgery made up at least 25% of their practice. There were 53% from private practice, 33% from academic medicine, and 14% in government settings. Amount of glenoid bone loss was the single most important factor driving surgeons to perform bony procedures over soft tissue procedures, followed by the patient age (19-25 years) and the patient activity level. The number of prior dislocations and glenoid track status did not have a strong influence on respondents' decision making. Twenty-one percent glenoid bone loss was the threshold of bone loss that influenced decision toward a bony procedure. If surgeons performed 10 or more open procedures per year, they were more likely to perform a bony procedure. Conclusion: The factors that drove surgeons to choose bony procedures were the amount of glenoid bone loss with the threshold at 21%, patient age, and their activity demands. Surprisingly, glenoid track status and the number of previous dislocations did not strongly influence surgical treatment decisions. Ten open shoulder procedures a year seems to provide a level of comfort to recommend bony treatment for shoulder instability.",
keywords = "Experts, Survey Study, bone loss, choice, conjoint analysis, contingent-behavior, shoulder instability",
author = "Lau, {Brian C.} and Hutyra, {Carolyn A.} and Gonzalez, {Juan Marcos} and Mather, {Richard C.} and Owens, {Brett D.} and Levine, {William N.} and Garrigues, {Grant E.} and Kelly, {John D.} and David Kovacevic and Abrams, {Jeffrey S.} and Frances Cuomo and McMahon, {Patrick J.} and Scott Kaar and Dines, {Joshua S.} and Anthony Miniaci and Sameer Nagda and Braman, {Jonathan P.} and Harrison, {Alicia K.} and Peter MacDonald and Riboh, {Jonathan C.}",
note = "Funding Information: Brian C. Lau is a board or committee member of the American Orthopaedic Society for Sports Medicine (AOSSM) and Arthroscopy Association of North America (AANA) and receives research support from Arthrex, Inc., and Wright Medical Technology, Inc.Grant Garrigues is a board or committee member of the ASES; receives other financial or material support from Arthrex, Inc., DJ Orthopaedics, and SouthTech; receives research support from Tornier; is a paid consultant for Bioventus, DJ Orthopaedics, Mitek, and Tornier; receives IP royalties from DJ Orthopaedics and Tornier; is a paid presenter or speaker for DJ Orthopaedics and Tornier; has stock or stock options in Genesys and ROM 3; is on the editorial or governing board of the Journal of Shoulder and Elbow Surgery (JSES) and Techniques in Orthopaedics.Joshua Dines is a board or committee member of the ASES; receives research support from, is a paid consultant, and a paid presenter or speaker for Arthrex, Inc.; is on the editorial or governing board of JSES; receives IP royalties from Linvatec; and publishing royalties and financial or material support from Thieme and Wolters Kluwer Health–Lippincott Williams & Wilkins.Anthony Miniaci is a board or committee member of the AOSSM, ASES, AANA, and the International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine; receives research support and IP royalties from Arthrosurface; is a paid consultant for Arthrosurface and Trice; is a paid presenter or speaker for Arthrosurface; has stock or stock options in Arthrosurface, DePuy, A Johnson & Johnson Company, Medtronic, Stryker, Trice, and Zimmer; other financial or material support from Arthrosurface and Stryker; is on the editorial or governing board of and receives publishing royalties and financial or material support from Wolters Kluwer Health–Lippincott Williams & Wilkins.Alicia Harrison is a board or committee member of ACS and Minnesota Orthopaedic Society and is a paid presenter or speaker for Arthrex, Inc.Peter MacDonald receives research support from Arthrex, Inc., Conmed Linvatec, and Ossur; is a board or committee member of the Canadian Orthopaedic Association (COA); and is on the editorial or governing board of JSES and the Clinical Journal of Sports Medicine. Publisher Copyright: {\textcopyright} 2020 Journal of Shoulder and Elbow Surgery Board of Trustees",
year = "2021",
month = mar,
doi = "10.1016/j.jse.2020.07.003",
language = "English (US)",
volume = "30",
pages = "e85--e102",
journal = "Journal of Shoulder and Elbow Surgery",
issn = "1058-2746",
publisher = "Mosby Inc.",
number = "3",
}